Jun 2, 2022   SOURCE: BusinessWire

Global Sunitinib Malate Market Report to 2027 - Featuring Active Biotech, Astellas Pharma, AstraZeneca and Bristol Myers Squibb Among Others - ResearchAndMarkets.com

The "Sunitinib Malate Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The global sunitinib malate market is anticipated to grow at a considerable CAGR during the forecast period. The increasing prevalence of the gastrointestinal disorder is a creating demand for sunitinib malate market.

Expanding geriatric populace coupled with rising cases of pancreatic cancer are further supporting the growth of the global sunitinib malate market.

The global sunitinib malate market is segmented based on application. Based on application, the sunitinib malate market is segmented into pancreatic neuroendocrine tumors, advanced kidney cancer, gastrointestinal stromal tumor (GIST), and other.

Geographically, the global sunitinib malate market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Companies Mentioned

  • Active Biotech AB
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Dendreon
  • Endo International plc
  • Ferring Pharmaceuticals Inc.
  • J&K Scientific
  • Pfizer Inc.
  • Targetmol
  • Top Care Pharmacy

The Report Covers

  • Comprehensive research methodology of the global sunitinib malate market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global sunitinib malate market.
  • Insights about market determinants that are stimulating the global sunitinib malate market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights

3. Market Determinants

3.1. Motivators

3.2. Restraints

3.3. Opportunities

4. Market Segmentation

4.1. Global Sunitinib Malate Market by Application

4.1.1. Pancreatic Neuroendocrine Tumors

4.1.2. Advanced Kidney Cancer

4.1.3. Gastrointestinal stromal tumour (GIST)

4.1.4. Other

5. Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. Rest of Asia-Pacific

5.4. Rest of the World

6. Company Profiles

6.1. Active Biotech AB

6.2. Astellas Pharma Inc.

6.3. AstraZeneca plc

6.4. Bristol Myers Squibb

6.5. Dendreon

6.6. Endo International plc

6.7. Ferring Pharmaceuticals Inc.

6.8. J&K Scientific

6.9. Pfizer Inc.

6.10. Targetmol

6.11. Top Care Pharmacy

For more information about this report visit https://www.researchandmarkets.com/r/6vqjt4